Top compounds associated with response to MAU2


Feature Type Standardized
Nominal ANOVA
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC 0.14 1e-05
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC 0.15 1e-05
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC 0.36 2e-05
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.15 3e-05
Download CSV